US Patent Issued to CELLECTIS on July 14 for "Methods for engineering allogeneic and highly active T cell for immunotheraphy" (French, American Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,680,076, issued on July 14, was assigned to CELLECTIS (Paris).

"Methods for engineering allogeneic and highly active T cell for immunotheraphy" was invented by Roman Galetto (Paris), Agnes Gouble (Paris), Stephanie Grosse (Saint Cyr sur Morin, France), Cecile Schiffer-Mannioui (Villiers sur Marne, France), Laurent Poirot (Paris), Andrew Scharenberg (Seattle) and Julianne Smith (Le Plessis Robinson, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for developing engineered T-cells for immunotherapy that are non-alloreactive. The present invention relates to methods for modifying T-cells by inactivating both g...